Novo Nordisk A-S

Yahoo Finance • 7 hours ago

Does Novo Nordisk’s Latest Earnings Dip Present a New Opportunity in 2025?

If you’re trying to decide what to do with Novo Nordisk stock right now, you’re not alone. It’s been quite a ride for investors lately, and there’s plenty to consider. Over the past week, shares have slipped by 4.5%, but zoom out just a bi... Full story

Yahoo Finance • 14 hours ago

Does Novo Nordisk’s Share Slide Signal a Rare Opportunity After Recent Drug Pricing Headlines?

If you are trying to figure out what’s next for Novo Nordisk’s stock, you are definitely not alone. There is a fair amount of chatter lately around where its share price is headed, and with good reason. The stock had a bumpy ride over the... Full story

Yahoo Finance • 16 hours ago

Should You Buy Novo Nordisk Right Now?

Key Points Novo Nordisk is drawing divided views from Wall Street analysts. Some may be disappointed by the loss of market share to Eli Lilly. Three events could turn sentiment positive in the coming months. 10 stocks we like better tha... Full story

Yahoo Finance • 16 hours ago

top global stories this week: HSBC, Novo Nordisk, Nikon among notable names

Most major stock indexes across the globe ended the week lower after President Donald Trump rattled markets with threats of a “massive” tariff hike [https://seekingalpha.com/news/4503345-trump-threatens-to-pull-out-of-xi-meeting-massive-ne... Full story

Yahoo Finance • yesterday

Notable healthcare headlines for the week: Novo Nordisk, Bristol Myers Squibb and J&J in focus

Tom Werner Wall Street's major averages plummeted on Friday after U.S. President Donald Trump threatened higher tariffs to China, saying it had "become very hostile" sending letters to other countries wanting to "impose export controls."... Full story

Yahoo Finance • yesterday

Key deals this week: Protagonist Therapeutics, Bristol Myers, Novo Nordisk, Fifth Third Bancorp and more

Here's a list of key deals reported across sectors this week: * Protagonist Therapeutics (NASDAQ:PTGX [https://seekingalpha.com/symbol/PTGX]), a biotech focused on peptide-based therapeutics, traded ~30% higher on Friday after The Wall... Full story

Yahoo Finance • 2 days ago

Update: Market Chatter: Novo Nordisk Halts Cell Therapy Work on Diabetes to Cut Costs

(Updates to add the company's response in fifth paragraph.) Novo Nordisk (NVO) is winding down it PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n... Full story

Yahoo Finance • 2 days ago

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were lower late Friday afternoon, with the NYSE Health Care Index down 1.4% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 days ago

Coinbase Reportedly Leads Mastercard In Bid For BVNK

This article first appeared on GuruFocus. Coinbase (NASDAQ:COIN) and Mastercard (NYSE:MA) are both eyeing a major move into stablecoin payments. The two companies have been in advanced talks to acquire BVNK, a London-based fintech that bu... Full story

Yahoo Finance • 2 days ago

Tesla China EV Sales Rise 2.8% in September After Two-Month Decline

This article first appeared on GuruFocus. Tesla (TSLA, Financials) saw a small but welcome rebound in China last month. After two straight months of declines, the company's local deliveries rose 2.8% from a year earlier to 90,812 vehicles... Full story

Yahoo Finance • 2 days ago

Global Protein Drugs Market to Reach $655.7 Billion by 2029

BCC Research LLC “BCC Research analyzes how innovation in biomanufacturing, ESG trends, and strategic investments are shaping the next frontier of protein-based therapeutics.” Boston, Oct. 10, 2025 (GLOBE NEWSWIRE) -- As demand for targe... Full story

Yahoo Finance • 3 days ago

Market Chatter: Novo Nordisk Halts Cell Therapy Work on Diabetes to Cut Costs

Novo Nordisk (NVO) is winding down its cell therapy division that had been working on a potential cu PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

Novo Nordisk said to be closing its cell therapy unit

[New Nordisk] hapabapa/iStock Editorial via Getty Images Ozempic maker Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new... Full story

Yahoo Finance • 3 days ago

Metals & Mining Virtual Investor Conference: Presentations Now Available for Online Viewing

NEW YORK, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Metals & Mining Virtual Investor Conference, held October 7-9th are... Full story

Yahoo Finance • 3 days ago

Market Chatter: Gates Foundation, PAHO Eye Expanded Access to Weight-Loss Drugs in Lower-Income Countries

The Gates Foundation and the Pan American Health Organization, or PAHO, are looking to expand access PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 days ago

Bill Gates, PAHO consider ways to expand access to Wegovy and Mounjaro in low-income countries - report

[Diet pills on bathroom scales with bokeh and zoom effect] wwing/iStock via Getty Images * The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo Nordisk's (NVO [https:... Full story

Yahoo Finance • 3 days ago

Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger

We recently published 10 Big Names With Whopping Gains; 6 Jump All-Time Highs. Akero Therapeutics, Inc. (NASDAQ:AKRO) is one of the best performers on Thursday. Akero Therapeutics saw its share prices jump by 16.33 percent on Thursday to... Full story

Yahoo Finance • 4 days ago

Stocks making the biggest moves midday: Oracle, Ferrari, Delta, Albemarle and more

Check out the companies making the biggest moves in midday trading: Oracle — Shares of the software company rose more than 3% on Thursday after Baird initiated coverage with a outperform rating and a $365 price taget. The firm said Oracle... Full story

Yahoo Finance • 4 days ago

Top Stock Movers Now: Delta Air Lines, PepsiCo, Akero Therapeutics, and More

Joan Valls / Urbanandsport / NurPhoto via Getty Images Shares of Delta Air Lines surged after the carrier posted better-than-expected results and issued a rosy current-quarter outlook Key Takeaways Major U.S. equities indexes pulled back... Full story

Yahoo Finance • 4 days ago

Novo Nordisk to Buy Akero Therapeutics in $5.2 Billion Deal

Novo Nordisk (NVO) agreed to acquire Akero Therapeutics (AKRO) for up to $5.2 billion as the Danish PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story